OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus
Manish Gutch, Abhay Joshi, Sukriti Kumar, et al.
Indian Journal of Endocrinology and Metabolism (2017) Vol. 21, Iss. 6, pp. 898-898
Open Access | Times Cited: 14
Manish Gutch, Abhay Joshi, Sukriti Kumar, et al.
Indian Journal of Endocrinology and Metabolism (2017) Vol. 21, Iss. 6, pp. 898-898
Open Access | Times Cited: 14
Showing 14 citing articles:
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Magdalena Złotek, Antonina Kurowska, Mariola Herbet, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3035-3035
Open Access | Times Cited: 17
Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 374-387
Open Access | Times Cited: 38
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 374-387
Open Access | Times Cited: 38
In-lab synthesized turn-off fluorescence sensor for estimation of Gemigliptin and Rosuvastatin polypill appraised by Spider diagram, AGREE and whiteness metrics
Sara M. Mohyeldin, Wael Talaat, Miranda F. Kamal, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Sara M. Mohyeldin, Wael Talaat, Miranda F. Kamal, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning
Maryam Rameshrad, Bibi Marjan Razavi, Gordon A. Ferns, et al.
DARU Journal of Pharmaceutical Sciences (2019) Vol. 27, Iss. 1, pp. 341-360
Open Access | Times Cited: 32
Maryam Rameshrad, Bibi Marjan Razavi, Gordon A. Ferns, et al.
DARU Journal of Pharmaceutical Sciences (2019) Vol. 27, Iss. 1, pp. 341-360
Open Access | Times Cited: 32
Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial
Thananda Trakarnvanich, Bancha Satirapoj, Swangjit Suraamornkul, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 16
Thananda Trakarnvanich, Bancha Satirapoj, Swangjit Suraamornkul, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 16
Exploring the recent molecular targets for diabetes and associated complications
Amit Gupta, Tapan Behl, Aayush Sehgal, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 3, pp. 2863-2879
Closed Access | Times Cited: 12
Amit Gupta, Tapan Behl, Aayush Sehgal, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 3, pp. 2863-2879
Closed Access | Times Cited: 12
Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
Yaochen Xie, Qian Zhou, Qiaojun He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2383-2402
Open Access | Times Cited: 7
Yaochen Xie, Qian Zhou, Qiaojun He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2383-2402
Open Access | Times Cited: 7
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
Sagnik Nag, Oishi Mitra, Bhanu Maturi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100927-100927
Open Access | Times Cited: 1
Sagnik Nag, Oishi Mitra, Bhanu Maturi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100927-100927
Open Access | Times Cited: 1
Efficient integration of analytical quality-by-design and tri-hued HPLC-DAD approach for synchronized assessment of gemigliptin and rosuvastatin in their fixed-dose pills: Application to stability study
Sara M. Mohyeldin, Hoda G. Daabees, Wael Talaat, et al.
Sustainable Chemistry and Pharmacy (2024) Vol. 42, pp. 101777-101777
Closed Access | Times Cited: 1
Sara M. Mohyeldin, Hoda G. Daabees, Wael Talaat, et al.
Sustainable Chemistry and Pharmacy (2024) Vol. 42, pp. 101777-101777
Closed Access | Times Cited: 1
Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients
Theerawut Klangjareonchai, Natsuki Eguchi, Ekamol Tantisattamo, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 413-413
Open Access | Times Cited: 9
Theerawut Klangjareonchai, Natsuki Eguchi, Ekamol Tantisattamo, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 413-413
Open Access | Times Cited: 9
The vasodilatory effect of gemigliptin via activation of voltage-dependent K+ channels and SERCA pumps in aortic smooth muscle
Hee Seok Jung, Mi Seon Seo, Jin Ryeol An, et al.
European Journal of Pharmacology (2020) Vol. 882, pp. 173243-173243
Closed Access | Times Cited: 4
Hee Seok Jung, Mi Seon Seo, Jin Ryeol An, et al.
European Journal of Pharmacology (2020) Vol. 882, pp. 173243-173243
Closed Access | Times Cited: 4
Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of anti-diabetic drug
Hae Jin Kim, Eun Bok Baek, Sung Joon Kim
Korean Journal of Physiology and Pharmacology (2018) Vol. 22, Iss. 6, pp. 713-713
Open Access | Times Cited: 3
Hae Jin Kim, Eun Bok Baek, Sung Joon Kim
Korean Journal of Physiology and Pharmacology (2018) Vol. 22, Iss. 6, pp. 713-713
Open Access | Times Cited: 3
Opportunities and challenges of incretins-based hypoglycemic agents treating of T2DM from the insight of physiological disposition
Yaochen Xie, Qiaojun He, Xiaoyi Wang, et al.
Authorea (Authorea) (2024)
Open Access
Yaochen Xie, Qiaojun He, Xiaoyi Wang, et al.
Authorea (Authorea) (2024)
Open Access
Effect of Dipeptidyl Peptidase- 4 (DPP-4) Inhibitor on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Nephropathy: A Randomized Controlled Trial
Thananda Trakarnvanich, Bancha Satirapoj, Sawangjit Suraamornkul, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Thananda Trakarnvanich, Bancha Satirapoj, Sawangjit Suraamornkul, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
